Schering-Plough, Merck&s Vytorin Fails Artery Study (Update1) - Bloomberg
Dog Flu Diet and DiseasesSchering-Plough, Merck's Vytorin Fails Artery Study Update1Bloomberg - 29 minutes agoBy Shannon Pettypiece and Michelle Fay Cortez March 30 Bloomberg -- Merck & Co. and Schering-Plough Corp.'s cholesterol pill Vytorin didn't slow clogging of the arteries better than an older, cheaper drug, prompting doctors to say the medicine should ...Journal Issues Warning on Two Cholesterol Drugs New York TimesVytorin Study Shows Little Change In Artery Thickness CNNMoney.comForbes - Wall Street Journal - Reuters - WANDall 86 news articles
